The positive interim results of the Phase 1a SAD/MAD trial support rapid advancement of clinical development. Aclaris expects to initiate a Phase 1b POC trial in AD imminently and a Phase 1b POC trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback